Literature DB >> 14874459

Antithyroid activity of 2-carbethoxythio-1-methylglyoxaline.

A LAWSON, C RIMINGTON, C E SEARLE.   

Abstract

Entities:  

Keywords:  HYPERTHYROIDISM/therapy

Mesh:

Year:  1951        PMID: 14874459     DOI: 10.1016/s0140-6736(51)92892-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Antithyroid substances. 3. Derivatives of 2-mercaptoglyoxalines.

Authors:  A LAWSON; C E SEARLE
Journal:  Biochem J       Date:  1955-02       Impact factor: 3.857

2.  Plasma concentrations of methimazole, a metabolite of carbimazole, in hyperthyroid patients.

Authors:  G G Skellern; J B Stenlake; W D Williams; D G McLarty
Journal:  Br J Clin Pharmacol       Date:  1974-06       Impact factor: 4.335

3.  Hair loss in patients treated with carbimazole.

Authors:  S Papadopoulos; R M Harden
Journal:  Br Med J       Date:  1966-12-17

4.  The effect of thyroid hormone on calcium-induced nephrocalcinosis in the jird (Meriones Unguiculatus).

Authors:  R J Newman
Journal:  Calcif Tissue Res       Date:  1974

Review 5.  Pharmacokinetics of antithyroid drugs.

Authors:  G Benker; D Reinwein
Journal:  Klin Wochenschr       Date:  1982-06-01

6.  Pharmacokinetic properties and bioavailability of methimazole.

Authors:  R Jansson; B Lindström; P A Dahlberg
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

7.  Antithyroid activity of thiohydantoins.

Authors:  R KILPATRICK; D T ELMORE; D R WOOD
Journal:  Br J Pharmacol Chemother       Date:  1958-09

Review 8.  Clinical pharmacokinetics of antithyroid drugs.

Authors:  J P Kampmann; J M Hansen
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

9.  Carbimazole (neo-mercazole) in thyrotoxicosis--a review of sixty patients.

Authors:  M W BOYD
Journal:  Ulster Med J       Date:  1959-11-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.